Adlai Goldberg | Social and Commercial Innovation Leader

Adlai Goldberg, Social and Commercial Innovation Leader, EY

As EY Global Life Sciences Digital, Social and Commercial Innovation Leader, Adlai is focused on developing the necessary digital infrastructure to support emerging, next-generation forms of individualized therapies to tackle cancer and rare diseases.
Adlai is the solutions leader for Pointellis™, an open, trusted data exchange platform and suite of applications that links all the key players in the cell and gene therapy (CGT) treatment ecosystem involved in a patient’s treatment journey.  
Recently, Adlai who, as a result of all the hard work from the EY Pointellis™ team, was named by PharmaVoice as one of their most 100 inspiring people of 2020.
Having a keen interest in different cultures, Adlai has chosen to spend his career living and working around the world in many markets including Japan, Thailand, Hong Kong, Indonesia, Ukraine, Russia and Switzerland.
With more than 28 years of professional experience in media, communications and consulting to his credit, Adlai helped establish EY global social media services and analytics hub. Additionally, he has also helped launch the world’s first interactive television platform in Hong Kong.


Day 3: Friday 21st May 2021 - Commercialisation, Pricing & Access @ 13:30

Overcoming pain points in the CGT value chain by creating a scalable and collaborative ecosystem

·This session will feature interviews with leaders in Biopharma and logistics as they discuss their pain points as they move cell and gene therapies into commercialization.
last published: 10/May/21 08:45 GMT

back to speakers